Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Neurology (clinical),Pharmacology
Link
http://link.springer.com/article/10.1007/s13311-017-0548-5/fulltext.html
Reference70 articles.
1. Ma VY, Chan L, Carruthers KJ. Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil 2014;95(5):986-95 e1.
2. Buraga I, Popovici RE. Multiple sclerosis and pregnancy: current considerations. ScientificWorldJournal 2014;2014:513160.
3. Achiron A, Chapman J, Magalashvili D, et al. Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLOS ONE 2013;8(8):e71058.
4. Dutta R, Trapp BD. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 2011;93(1):1-12.
5. Grytten N, Torkildsen O, Myhr KM. Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. Acta Neurol Scand 2015;132:29-36.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Introduction to Neurodegenerative Diseases;Advances in Medical Diagnosis, Treatment, and Care;2024-02-14
2. The therapeutic effect of gold clusters in an EAE model of multiple sclerosis by regulating T cell differentiation;Nano Today;2024-02
3. An update on managing patients with multiple sclerosis in primary care;JAAPA;2024-01-17
4. Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China;Therapeutic Advances in Neurological Disorders;2024-01
5. Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis – real-world evidence from Germany;Therapeutic Advances in Neurological Disorders;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3